JAX steps up fight re opioids and rare diseases

Independent nonprofit biomedical research institute The Jackson Laboratory (JAX) has teamed with Lovelace Biomedical, Exemplar Genetics, Iontox and the University of Pennsylvania to win a new $17M contract with the National Institute of Health’s National Center for the Advancement of Translational Sciences, for the purposes of creating new animal models and performing pharmacology studies to better understand and study diseases or treatments, especially for rare and neglected diseases…more

As health experts and politicians work to contain the unfolding opioid addiction crisis, JAX scientists in Bar Harbor and their colleagues in Connecticut are intensifying their efforts to shed light on the genetic and neurobiological causes of addiction, along with the impact of environmental influences…more